"Randomized clinical trial of neoadjuvant chemotherapy with denosumab compared to chemotherapy alone in hormonal receptor-positive, HER2-negative premenopausal breast cancer patients"

drug protocol number
20-610
drug sponsor
King Abdullah Medical City
drug study
DENOSUMAB
drug trial site
King Abdullah Medical City (Makkah)
drug status
Ongoing
drug phase